Basf Corporation

Merck Sharp + Dohme Corp.

Engelhard Corporation

Schering Corporation

David Hamilton Harris

David M Stockwell

Xingtao Gao

Junmei Wei

Joel A Sequeira

Rostam Jai Madon

Mingting Xu

Glenn W Dodwell

Imtiaz A Chaudry

Majid Mahjour

Bruce A Lerner

David C Dubost

Shashank Mahashabde

Stefan Sharpe

Dan Zhang

Lixia Cai

Yongjun Li

A bottoms cracking catalyst composition, comprising: about 30 to about 60 wt % alumina; greater than 0 to about 10 wt % of a dopant, measured as the oxide; about 2 to about 20 wt % reactive silica; about 3 to about 20 wt % of a component comprising peptizable boehmite, colloidal silica, aluminum chlorohydrol, or a combination of any two or more thereof, and about 10 to about 50 wt % of kaolin.

Reactive silica-alumina matrix component compositions for bottoms cracking catalysts

A bottoms cracking catalyst composition, comprising: about 30 to about 60 wt % alumina; greater than 0 to about 10 wt % of a dopant, measured as the oxide; about 2 to about 20 wt % reactive silica; about 3 to about 20 wt % of a component comprising peptizable boehmite, colloidal silica, aluminum chlorohydrol, or a combination of any two or more thereof; and about 10 to about 50 wt % of kaolin.

Disclosed are pharmaceutical compositions comprising tedizolid phosphate, methods of preparing such pharmaceutical compositions, and methods of treating bacterial infections with such pharmaceutical compositions. Specifically, a pharmaceutical composition comprising tedizolid phosphate, an acid; and a suspending agent; and wherein the pH of the composition upon constitution with water is between about pH 2-4.5, is provided, wherein the acid is not citric acid or malic acid.

Pharmaceutical compositions of tedizolid phosphate

A catalytic additive comprising an intermediate pore zeolite, such as ZSM-5 is treated so as to improve propylene yields when the additive is included in a FCC catalytic inventory by first treating the zeolite with a phosphorus compound to incorporate the phosphorus in the zeolite, and mixing the P-treated zeolite with a matrix component comprising kaolin and another phosphorus-containing compound.

ZSM-5 additive activity enhancement by improved zeolite and phosphorus interaction

A catalyst composition resulting in increased propylene yields during fluid catalytic cracking processes comprises (i) Y zeolite, (ii) ZSM-5 zeolite, and (iii) Beta zeolite.

Catalyst to increase propylene yields from a fluid catalytic cracking unit

A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: at least one thickening agent, a non-ionic surfactant, and a pharmaceutically acceptable liquid carrier is disclosed.

Antifungal composition with enhanced bioavailability

A fluid catalytic cracking catalyst made from microspheres that initially contain kaolin, a dispersible boehmite alumina and a sodium silicate or silica sol binder. The kaolin portion contains hydrous kaolin and optionally spinel, or mullite, or both spinel and mullite made via kaolin which has been calcined through its characteristic exotherm. Calcination of the hydrous clay to metakaolin and formation of in-situ zeolite by treatment with sodium silicate yields a catalyst containing Y-faujasite and transforms the dispersible boehmite into a transitional alumina. The catalyst can be used to crack resid or resid-containing feeds as the alumina phase formed from the dispersible boehmite passivates nickel and vanadium contaminants.

FCC catalysts for feeds containing nickel and vanadium

A fluid catalytic cracking catalyst made from microspheres that initially contain kaolin, a dispersible boehmite alumina and a sodium silicate or silica sol binder. The kaolin portion contains hydrous kaolin and a particular kaolin which has been calcined through its characteristic exotherm and which produces a catalyst having a novel morphology comprising a macroporous matrix and crystallized zeolite freely coating the walls of the pores of the matrix. Calcination of the hydrous kaolin to metakaolin and formation of in-situ zeolite by treatment with sodium silicate yields a catalyst containing Y-faujasite and transforms the dispersible boehmite into a transitional alumina. The catalyst can be used to crack resid or resid-containing feeds as the alumina phase formed from the dispersible boehmite passivates nickel and vanadium contaminants.

An aqueous nebulizer suspension contains water, mometasone furoate monohydrate, a nonionic surfactant, a soluble salt and optionally a pH buffer. The suspension may be prepared by ultrasonication or jet milling techniques.

Growing community of inventors

Mountainside, NJ, United States of America

David Hamilton Harris